Funds holding Foghorn Therapeutics Inc
ISIN US3441741077 · United States
- Fund holders
- 101
- Of which ETFs
- 12 89 other funds
- Value held
- 40.9M $
- Share of capital
- 13.2 % of 59.4M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 8 | 45.4 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.26 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 0.07 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.03 % | as of Mar 31, 2026 ↗ |
| NVIT Small Cap Value Fund Nationwide Variable Insurance Trust | 0.03 % | as of Mar 31, 2026 ↗ |
| PACE Small/Medium Co Growth Equity Investments PACE SELECT ADVISORS TRUST | 0.03 % | as of Apr 30, 2026 ↗ |
| NVIT Multi-Manager Small Company Fund Nationwide Variable Insurance Trust | 0.02 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 0.02 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Small Cap Growth Insights Fund Goldman Sachs Trust | 0.02 % | as of Apr 30, 2026 ↗ |
| SMALL COMPANY GROWTH PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 0.02 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.02 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 101 | +4 | 7,826,476 | +11.5 % |
| 2026Q1 | 97 | -2 | 7,018,462 | -0.8 % |
| 2025Q4 | 99 | +1 | 7,073,755 | -1.0 % |
| 2025Q3 | 98 | -9 | 7,142,054 | +3.9 % |
| 2025Q2 | 107 | +8 | 6,872,181 | -7.2 % |
| 2025Q1 | 99 | -1 | 7,405,907 | -1.2 % |
| 2024Q4 | 100 | +11 | 7,493,591 | +14.3 % |
| 2024Q3 | 89 | +6 | 6,556,353 | +62.6 % |
| 2024Q2 | 83 | -2 | 4,032,435 | -1.7 % |
| 2024Q1 | 85 | -4 | 4,104,139 | -4.4 % |
| 2023Q4 | 89 | 4,293,271 |
Institutional managers
100 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Flagship Pioneering, LLC | 12,674,120 | 60.6M $ | as of Mar 31, 2026 |
| FMR LLC | 6,047,198 | 28.9M $ | as of Mar 31, 2026 |
| BVF INC/IL | 5,842,000 | 27.9M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 4,394,367 | 21M $ | as of Mar 31, 2026 |
| RAYMOND JAMES FINANCIAL INC | 2,602,382 | 12.4M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 2,364,866 | 11.3M $ | as of Mar 31, 2026 |
| Euclidean Capital LLC | 1,573,761 | 7.5M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 848,172 | 4.1M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 720,720 | 3.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 679,787 | 3.2M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 448,976 | 2.1M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 406,425 | 1.9M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 313,765 | 1.5M $ | as of Mar 31, 2026 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 303,757 | 1.5M $ | as of Mar 31, 2026 |
| Birchview Capital, LP | 281,730 | 1.3M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 275,875 | 1.3M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 200,013 | 956.1K $ | as of Mar 31, 2026 |
| Woodline Partners LP | 180,333 | 862K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 136,108 | 650.6K $ | as of Mar 31, 2026 |
| Sio Capital Management, LLC | 122,889 | 587.4K $ | as of Mar 31, 2026 |
| PANAGORA ASSET MANAGEMENT INC | 115,063 | 550K $ | as of Mar 31, 2026 |
| DAFNA Capital Management LLC | 111,859 | 534.7K $ | as of Mar 31, 2026 |
| SCS Capital Management LLC | 106,980 | 511.4K $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 103,743 | 495.9K $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 103,525 | 494.9K $ | as of Mar 31, 2026 |
Declared shareholders of Foghorn Therapeutics Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 11.60 % | 6,792,356 | as of Mar 31, 2026 · SCHEDULE 13G |
| BIOTECHNOLOGY VALUE FUND L P and 9 others | 9.99 % | 5,866,613 | as of Mar 31, 2026 · SCHEDULE 13G |
| Deerfield Mgmt, L.P. and 3 others | 8.64 % | 5,139,523 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Foghorn Therapeutics Inc". https://titelia.com/en/stocks/foghorn-therapeutics-inc-US3441741077